News | March 22, 2022
Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
Read More
Press Release | March 1, 2022
Dragonfly Therapeutics Announces Achievement of Phase 1 Clinical Development Milestone for IL-12 Investigational Immunotherapy Program with Bristol Myers Squibb
Read More
Press Release | February 28, 2022
Freenome Launches the Vallania Study for the Early Detection of Multiple Cancers
Read More
News | February 28, 2022
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Fibromyalgia
Read More
